Mitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation.

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Parkinson's Disease (PD) is often sporadic, with atypical forms like Progressive Supranuclear Palsy (PSP) accounting for a significant portion.
• PSP is histopathologically classified as a tauopathy, highlighting the role of tau protein in neurodegeneration.

Purpose of the Study:

• To investigate mitochondrial function in mesenchymal stem cells (MSCs) derived from PSP patients.
• To explore the impact of mitochondrial dysfunction on MSC stemness and differentiation capabilities.

Main Methods:

• Isolation and characterization of bone marrow-derived MSCs from PSP patients.
• Assessment of mitochondrial function, including membrane potential, respiration, ROS generation, and antioxidant levels (GSH).
• Evaluation of mitochondrial mass, degradation, biogenesis, and adipogenic differentiation potential, including gene expression analysis (PPARγ, FABP4).

Main Results:

• PSP-MSCs exhibited mitochondrial dysfunction, characterized by decreased membrane potential and impaired NADH respiration.
• Increased mitochondrial ROS generation and oxidative stress were observed, leading to reduced GSH levels.
• PSP-MSCs showed reduced mitochondrial mass due to increased degradation and decreased biogenesis, impairing adipogenic differentiation and lipid droplet formation.

Conclusions:

• Mitochondrial dysfunction is a key feature in PSP-MSCs, affecting their stemness and differentiation.
• These findings offer insights into the etiology of 'idiopathic' parkinsonism, emphasizing the role of mitochondrial defects.
• Mitochondrial dysfunction contributes to parkinsonism pathogenesis irrespective of the specific cell type involved.